These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19258313)

  • 21. The hepatic FOXQ1 transcription factor regulates glucose metabolism in mice.
    Cui Y; Qiao A; Jiao T; Zhang H; Xue Y; Zou Y; Cui A; Fang F; Chang Y
    Diabetologia; 2016 Oct; 59(10):2229-39. PubMed ID: 27421728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myricitrin Ameliorates Hyperglycemia, Glucose Intolerance, Hepatic Steatosis, and Inflammation in High-Fat Diet/Streptozotocin-Induced Diabetic Mice.
    Kim DY; Kim SR; Jung UJ
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of hepatic neuregulin 4 in the regulation of gluconeogenesis in mice.
    Zhang L; Bai M; Tang H; Zhou F; Zhu Q; Wang S; Zhu K; Liu Q; Liu Y; Wang X; Ma Y; Zhou L
    Life Sci; 2019 Jan; 217():185-192. PubMed ID: 30528184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major urinary protein 1 interacts with cannabinoid receptor type 1 in fatty acid-induced hepatic insulin resistance in a mouse hepatocyte model.
    Chen CC; Lee TY; Kwok CF; Hsu YP; Shih KC; Lin YJ; Ho LT
    Biochem Biophys Res Commun; 2015 May; 460(4):1063-8. PubMed ID: 25843798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenovirus-mediated expression of SIK1 improves hepatic glucose and lipid metabolism in type 2 diabetes mellitus rats.
    Song D; Yin L; Wang C; Wen X
    PLoS One; 2019; 14(6):e0210930. PubMed ID: 31233505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NFIL3 is a negative regulator of hepatic gluconeogenesis.
    Kang G; Han HS; Koo SH
    Metabolism; 2017 Dec; 77():13-22. PubMed ID: 29132537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
    Singh V; Grötzinger C; Nowak KW; Zacharias S; Göncz E; Pless G; Sauer IM; Eichhorn I; Pfeiffer-Guglielmi B; Hamprecht B; Wiedenmann B; Plöckinger U; Strowski MZ
    Endocrinology; 2007 Aug; 148(8):3887-99. PubMed ID: 17525126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. knocking down liver ccaat/enhancer-binding protein alpha by adenovirus-transduced silent interfering ribonucleic acid improves hepatic gluconeogenesis and lipid homeostasis in db/db mice.
    Qiao L; MacLean PS; You H; Schaack J; Shao J
    Endocrinology; 2006 Jun; 147(6):3060-9. PubMed ID: 16543372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of low-carbohydrate diet and ketogenic diet on glucose and lipid metabolism in type 2 diabetic mice.
    Yang Z; Mi J; Wang Y; Xue L; Liu J; Fan M; Zhang D; Wang L; Qian H; Li Y
    Nutrition; 2021 Sep; 89():111230. PubMed ID: 33838492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocyte Rap1a contributes to obesity- and statin-associated hyperglycemia.
    Wang Y; Spolitu S; Zadroga JA; Sarecha AK; Ozcan L
    Cell Rep; 2022 Aug; 40(8):111259. PubMed ID: 36001955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amelioration of glucose tolerance by hepatic inhibition of nuclear factor kappaB in db/db mice.
    Tamura Y; Ogihara T; Uchida T; Ikeda F; Kumashiro N; Nomiyama T; Sato F; Hirose T; Tanaka Y; Mochizuki H; Kawamori R; Watada H
    Diabetologia; 2007 Jan; 50(1):131-41. PubMed ID: 17093946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
    Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression.
    Zhang W; Patil S; Chauhan B; Guo S; Powell DR; Le J; Klotsas A; Matika R; Xiao X; Franks R; Heidenreich KA; Sajan MP; Farese RV; Stolz DB; Tso P; Koo SH; Montminy M; Unterman TG
    J Biol Chem; 2006 Apr; 281(15):10105-17. PubMed ID: 16492665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
    Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B
    J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dexamethasone-induced Krüppel-like factor 9 expression promotes hepatic gluconeogenesis and hyperglycemia.
    Cui A; Fan H; Zhang Y; Zhang Y; Niu D; Liu S; Liu Q; Ma W; Shen Z; Shen L; Liu Y; Zhang H; Xue Y; Cui Y; Wang Q; Xiao X; Fang F; Yang J; Cui Q; Chang Y
    J Clin Invest; 2019 Apr; 129(6):2266-2278. PubMed ID: 31033478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the novel Foxo1 inhibitor AS1708727 on plasma glucose and triglyceride levels in diabetic db/db mice.
    Tanaka H; Nagashima T; Shimaya A; Urano Y; Shimokawa T; Shibasaki M
    Eur J Pharmacol; 2010 Oct; 645(1-3):185-91. PubMed ID: 20655898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis.
    Ploton M; Mazuy C; Gheeraert C; Dubois V; Berthier A; Dubois-Chevalier J; Maréchal X; Bantubungi K; Diemer H; Cianférani S; Strub JM; Helleboid-Chapman A; Eeckhoute J; Staels B; Lefebvre P
    J Hepatol; 2018 Nov; 69(5):1099-1109. PubMed ID: 29981427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E2F1 promotes hepatic gluconeogenesis and contributes to hyperglycemia during diabetes.
    Giralt A; Denechaud PD; Lopez-Mejia IC; Delacuisine B; Blanchet E; Bonner C; Pattou F; Annicotte JS; Fajas L
    Mol Metab; 2018 May; 11():104-112. PubMed ID: 29526568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nighttime Administration of Nicotine Improves Hepatic Glucose Metabolism via the Hypothalamic Orexin System in Mice.
    Tsuneki H; Nagata T; Fujita M; Kon K; Wu N; Takatsuki M; Yamaguchi K; Wada T; Nishijo H; Yanagisawa M; Sakurai T; Sasaoka T
    Endocrinology; 2016 Jan; 157(1):195-206. PubMed ID: 26492471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of eugenol on hepatic glucose production and AMPK signaling pathway in hepatocytes and C57BL/6J mice.
    Jeong KJ; Kim DY; Quan HY; Jo HK; Kim GW; Chung SH
    Fitoterapia; 2014 Mar; 93():150-62. PubMed ID: 24418657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.